Today's Top Stories
View all
The Pelvic Parameter That's Tired of Living in PI's Shadow
Bundle Up: CMS Mandates TJR Reimbursement Bundling Nationwide
Vancomycin Powder: No Need to Rewrite the Playbook
Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone
People in the News
View all
Dr. Gabriele P. Jasper, MD (1955–2026)
Jul 23, 2026
10% of Surgeons Leave Their Profession Mid-Career
Jun 5, 2026
Martin ‘Marty’ Altshuler Dies Age 65
May 27, 2026
A Spine Surgeon Built an AI Tool to Solve One of the OR’s Most Frustrating Problems. 50,000 Users Later, It’s Just Getting Started
May 6, 2026
Michael Parks, M.D. Steps into AAOS Presidential Line
Apr 20, 2026
UCSF Taps Rajiv Sethi to Lead Spine Surgery
Apr 15, 2026More Stories
View allWhen the Subtalar Joint Runs Out of Room
This is a great ankle osteoarthritis study. Must read for every foot and ankle surgeon.
The Hidden Tear That Could Undermine Your ACL Reconstruction
The ACL tunnels are perfect. Graft tension: ideal. Fixation: rock solid. Yet months later the patient still complains that something doesn't feel quite right.
Can the Lesser Trochanter Reveal Too Much?
Femoral version has become one of the most influential variables in modern hip preservation surgery.
The Second Clavicle Break Nobody Wants
How often do clavicle fractures re-break and could that hardware removal have played a role?
The MRI Cartilage Tumor Clue You May Be Overlooking
"Is this simply another chondrosarcoma — or is it something far more dangerous?"
Medacta Group SA: Medacta reports continued above-market revenue growth of 9.7% in c.c. in H1 2026
Medacta Group SA reports continued above-market revenue growth of 9.7% in c.c.1 in H1 2026 - H1 2026 revenue climbed to Euro 368 million, up 9.7% in c.c.1 or 7.0% in Euro - Sustained above market revenue growth across all geographic markets and business lines - FY 2026 and mid-term outlook confirmed
Affinity AI Launches B2B Marketplace for Compounded Peptides and GLP-1s
A new sourcing portal connects clinics with compounding pharmacies across peptides, GLP-1s, and other compounded therapeutics.
MIMEDX to Acquire Sanara MedTech
MiMedx Group, Inc. and Sanara MedTech Inc. today announced that they have entered into a definitive merger agreement under which MIMEDX will acquire all of the outstanding shares of Sanara.
Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation
Smith+Nephew announces it has been granted De Novo classification by the U.S. Food & Drug Administration (FDA) for its TESSA Spatial Surgery System.
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
Aclarion, Inc., announced the publication of a Shareholder Letter from CEO Brent Ness providing an update on the company’s recent momentum and value creating priorities through the first half of 2026.
VB Spine Receives FDA Clearances of Expanded Indications for Vitoss® Bone Graft Substitute and Interbody Cage Portfolio
VB Spine LLC announced that the FDA granted two 510(k) clearances that expand the indications for its Vitoss® Bone Graft Substitute and interbody cage portfolio.
Spinal Elements Launches Luna® Ti
Spinal Elements® announced the first clinical cases using Luna Ti, the newest addition to its Luna family of TLIF interbodies.
Industry Executives
